<DOC>
	<DOCNO>NCT00434525</DOCNO>
	<brief_summary>- The investigator aim determine clinical metabolic effect sleeve gastrectomy without omentectomy treatment morbid obesity . - The investigator hypothesize endocrine suppression ghrelin ( appetite hormone ) resistin ( insulin antagonist ) provide sleeve gastrectomy omentectomy ( omentum intra-abdominal fat removal ) provide clinical metabolic benefit morbidly obese patient .</brief_summary>
	<brief_title>Laparoscopic Sleeve Gastrectomy With Without Omentectomy</brief_title>
	<detailed_description>This phase 3 prospective randomize trial .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Morbidly obese VETERANS ONLY ( BMI &gt; 35 comorbidities BMI &gt; 40 ) Age &gt; 18 Pregnancy Uncontrolled medical psychiatric condition Previous bariatric procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Morbid obesity</keyword>
	<keyword>Bariatric Surgery</keyword>
	<keyword>Obesity Surgery</keyword>
	<keyword>Omentectomy</keyword>
	<keyword>Sleeve gastrectomy</keyword>
</DOC>